News

PAA Laboratories is a developer and manufacturer of specialized and cell culture products such as media, sera, growth supplements and reagents for use in biomedical research and in

The colon-screen will use Phloral coating technology to deliver the drug to the target site by applying two mechanisms to trigger drug release. The mechanism is based on

Eylea is indicated as a treatment for neovascular age-related macular degeneration (wet AMD). The extension of three months follows the recent amendment made by the company on the

The collaboration allows HGS to develop 4-Antibody’s proprietary in vitro Retrocyte Display technology (Retroviral B lymphocyte Display) to discover sources for antibody drug candidates. Retrocyte Display creates therapeutic

China Ruitai’s net income was $1.37m, compared to net income of $1.42m for the same period in the prior year. The company’s income from operations was $2.46m for

Revenue from the chemical products segment was $12.1m, or 23% of total revenue, for the second quarter of 2011, an increase of 3%from $11.8m in the corresponding period

The preclinical study results demonstrated that ME-143 showed anti-tumor activity against tumor cell lines, including breast, colorectal and ovarian. Additionally, ME-143 has also shown an ability to enhance

The milestone was paid for achieving key scientific milestones following independent scientific review of the company’s ongoing R&D projects. The payment is part of the previously announced five-year,

The Complete EHRs are 2011/2012 compliant and have been certified by InfoGard Laboratories, an ONC-ATCB certification body. Axolotl EMR Lite aids physicians to connect with the HIE and